123 related articles for article (PubMed ID: 11375764)
1. Phosphinic peptide inhibitors of macrophage metalloelastase (MMP-12). Selectivity and mechanism of binding.
Schiødt CB; Buchardt J; Terp GE; Christensen U; Brink M; Berger Larsen Y; Meldal M; Foged NT
Curr Med Chem; 2001 Jul; 8(8):967-76. PubMed ID: 11375764
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Matziari M; Beau F; Cuniasse P; Dive V; Yiotakis A
J Med Chem; 2004 Jan; 47(2):325-36. PubMed ID: 14711305
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.
Brown FK; Brown PJ; Bickett DM; Chambers CL; Davies HG; Deaton DN; Drewry D; Foley M; McElroy AB; Gregson M
J Med Chem; 1994 Mar; 37(5):674-88. PubMed ID: 8126708
[TBL] [Abstract][Full Text] [Related]
7. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
[TBL] [Abstract][Full Text] [Related]
8. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
9. Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.
Devel L; Garcia S; Czarny B; Beau F; LaJeunesse E; Vera L; Georgiadis D; Stura E; Dive V
J Biol Chem; 2010 Nov; 285(46):35900-9. PubMed ID: 20817735
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibitors: a structure-activity study.
Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
[TBL] [Abstract][Full Text] [Related]
12. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
13. The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.
Tullis JS; Laufersweiler MJ; VanRens JC; Natchus MG; Bookland RG; Almstead NG; Pikul S; De B; Hsieh LC; Janusz MJ; Branch TM; Peng SX; Jin YY; Hudlicky T; Oppong K
Bioorg Med Chem Lett; 2001 Aug; 11(15):1975-9. PubMed ID: 11454461
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.
Fray MJ; Burslem MF; Dickinson RP
Bioorg Med Chem Lett; 2001 Feb; 11(4):567-70. PubMed ID: 11229773
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase.
Bird J; De Mello RC; Harper GP; Hunter DJ; Karran EH; Markwell RE; Miles-Williams AJ; Rahman SS; Ward RW
J Med Chem; 1994 Jan; 37(1):158-69. PubMed ID: 8289190
[TBL] [Abstract][Full Text] [Related]
17. Development of selective inhibitors and substrate of matrix metalloproteinase-12.
Devel L; Rogakos V; David A; Makaritis A; Beau F; Cuniasse P; Yiotakis A; Dive V
J Biol Chem; 2006 Apr; 281(16):11152-60. PubMed ID: 16481329
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
19. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]